Module 1- Welcome note: Dr Shubhi from Medical Learning Hub welcomed the participants and the speakers Dr. Digambar Behera, and Dr Nazir Ismail describing the general instructions and the first poll was raised.
Module 2- Molecular Mechanism of Resistance: Padma Shri, Professor, Dr. Digambar Behera, General Medicine/Respiratory Medicine discussed about the mechanism responsible for TB. Key points discussed were:
- Definition of TB resistance
- DR TB
- Multidrug Resistant TB
- Causes of DR TB
- Periodic DR TB surveys in India
- Drug Resistance mechanism
- Acquired Drug resistance
- Important gene targets
- Intrinsic drug resistance
- Phenotypic drug tolerance
- Five major mechanism of drug tolerance
Module 3- Diagnostics for DR-TB: New tools recommended by WHO and a few other developments: Dr Nazir Ismail, Team Leader in the Unit for Prevention, Diagnosis, Treatment, Care and Innovation at the WHO’s Global Tuberculosis (TB) Programme in Geneva, Switzerland discussed about the newer tools that are used by WHO to diagnose TB. Key points of discussion were:
- Background of Diagnosing DR TB
- WHO recommended diagnostics
- Complexity of NAATs
- Reverse hybridization
- TB diagnostics
- Sequencing for drug resistance testing
Module 4- Q&A sessions: Several questions were asked during the session which were all answered by the speakers, Dr Nazir
Module 5- Vote of thanks- After Q&A session vote of thanks was shared by Dr Shubhi from Medical learning Hub and second poll was raised.
We wish you a great learning experience!
We thank Mylan Pharmaceuticals Private Limited, a Viatris Company for supporting us in the webinar
- Welcome Note & Pre poll
- Introduction to speakers
- Speaker 1: ADR TB & case presentation: Dr Neha Gupta , Senior Infectious Diseases Physician, First Batch of FNB ID in India, FMRI & Founder NG Swastha, Gurugram
- Speaker 2: Drug interaction with ATT & HIV drugs in ADR TB: Dr Pratibha Singhal; Consultant Chest Physician and Interventional Pulmonologist at Bombay Hospital & Sir H N Reliance Hospital, Mumbai
- Q&A session: Panelist
- Vote of Thanks
